在植物生长过程中进行了一系列新陈代谢生化过程,形成了多种化学物质,构成植物的复杂化学成分。这些物质种类繁多,不同部位含有不同的成分。一般而言,植物中含有以下几种类型的化学成分:生物碱、苷类、有机酸、树脂(包括树脂酸、树脂醇和树脂烃)、挥发油、糖类(如淀粉、菊淀粉、树胶和粘液质等)、氨基酸、蛋白质及酶、鞣质、植物色素(如叶绿素、胡萝卜素、黄酮类、甜菜红碱类和醌类)以及油脂、蜡和无机成分(微量元素)。
植物提取物种类多样,在皮肤药品、疗效化妆品和日常护肤品中,它们的主要功能包括抗刺激、消炎、促进伤口愈合、抗菌、消毒、滋润及保护皮肤。单一或复方的植物提取物都能发挥多种效能,尤其是复方提取物因其综合配伍作用而表现出更好的整体效果。
按剂型分类,植物提取物分为水溶性提取物(如用水和丙二醇、丁二醇等提取液)、油溶性提取物(如各种植物油及肉豆蔻异丙酯提取物)、精油、喷雾干燥粉、酶解蛋白粉、纯有效成分、去皮果实核的干粉、脂质体包封微囊、多糖或其他聚合物包封微囊和多孔微球吸收提取物等。此外,新鲜榨取的水果或蔬菜汁也在专业美容院及家庭护理中使用。
植物的有效成分因其所用部位不同而异,主要分为根、茎、叶、皮、花、花冠、果实、种子和幼芽等部分。这些分类在生产、应用、存储和运输方面具有重要意义,并被许多生产厂家采用。
随着提取、分离技术以及对其结构的研究不断进步,纯化植物提取物逐渐受到重视。一些化妆品公司积极开发此类产品,分离并制备纯净的提取物,应用于各类美容产品中。这类提取物的有效成分含量高,不含或仅含少量无关物质,并具有明确的质量标准和检验方法。尽管成本较高,但使用这些植物提取物能提高产品的防腐性能及质量控制水平。
中国的植物提取物产业因受传统中医药文化影响而具备独特优势,凭借着丰富的资源和技术支持,在国际市场上占据重要地位。2010年,我国植物提取物出口额达到8.15亿美元,占中药出口总额的41.9%,成为中药出口增长的主要动力。目前约有2000家企业从事植物提取物生产和贸易,每年出口上千种产品。
数据显示,2011年上半年,我国植物提取物出口额为5.25亿美元,同比增长47.68%。由于其作为“天然药物”和“顺势疗法”的应用,在国际市场拥有稳定的销路。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(+)-δ-生育酚 | delta tocopherol | 119-13-1 | C27H46O2 |
|
(+)-α-蒎烯 | (+)-α-pinene | 7785-70-8 | C10H16 |
|
—— | b-D-Glucopyranoside, (3b,25R)-spirost-5-en-3-ylO-6-deoxy-a-L-mannopyranosyl-(1®2)-O-[b-D-glucopyranosyl-(1®4)]- | 53846-52-9 | C45H72O17 |
|
—— | Pubchem_71571504 | 129741-57-7 | C60H98O26 |
|
—— | Isorhamnetin-7-O-α-L-rhamnopyranosid | 17331-72-5 | C22H22O11 |
|
—— | EUPHORBIASTEROID(P) | 28649-59-4 | C32H40O8 |
|
—— | EUPHORBIASTEROID(P) | 28649-59-4 | C32H40O8 |
|
—— | EUPHORBIASTEROID(P) | 28649-59-4 | C32H40O8 |
|
—— | PROTOGRACILLIN(P) | 54848-30-5 | C51H84O23 |
|
—— | (3R,4R,5S,6S)-2-methyl-6-[(9S,10R,13R,14S,17R)-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenan | 75801-95-5 | C42H72O15 |
|
—— | (Z)-4-[(1S,2S,8S,19R)-12-hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid | 887606-04-4 | C38H44O8 |
|
—— | Polygalasaponin XXXI | 79103-90-5 | C75H112O36 |
|
—— | Delphinidin-3-glucoside-chloride | 6906-38-3 | C21H21O12*Cl |
|
—— | [(1S,3R,18S,19R,20R,21R,22S,23R,24S,25R,26S)-19,22,23-triacetyloxy-21-(acetyloxymethyl)-25,26-dihydroxy-3,15,26-trimethyl-6,16-dioxo-2,5,17-trioxa-11-azapentacyclo[16.7.1.01,21.03,24.07,12]hexacosa-7(12),8,10-trien-20-yl] benzoate | 128397-42-2 | C41H47NO17 |
|
—— | N-Aminomethyldopa | 28860-95-9 | C10H13N2O4- |
|
—— | CID 154831908 | 74170-32-4 | C27H43NO3 |
|
—— | N-[5-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide | 83512-85-0 | C20H37N3O14 |
|
—— | 3,20-di-O-β-D-glucopyranosyl-dammar-24-ene-3α,12β,20(S)-triol | 62025-49-4 | C42H72O13 |
|
—— | saikosaponin-e | 64340-44-9 | C42H68O12 |
|
—— | Gitoxin | 4562-36-1 | C41H64O14 |
|
—— | vexibidin | 52483-02-0 | C26H30O6 |
|
—— | Gynuramide II | 295803-03-1 | C42H83NO5 |
|
—— | N,N'-4,10-dioxa-3,11-dioxotridecylene-1,13-diyl-bis-(S)-(+)-tetrahydropapaverine dioxalate | 64228-78-0 | 2C2H2O4*C51H66N2O12 |
|
—— | (RS)/meso-N,N'-4,10-dioxa-3,11-dioxotridecylene-1,13-diyl-bis-tetrahydropapaverine dioxalate | 64228-78-0 | 2C2H2O4*C51H66N2O12 |
|
—— | [2-hydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate | 117591-85-2 | C18H24O11 |
|
—— | (2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | 34096-83-8 | C36H54O10 |
|
—— | Kaempferol-7-rhamnoside | 69135-41-7 | C21H22O10 |
|
—— | Mitoridin | 3911-19-1 | C20H22N2O2 |
|
—— | momordin Ia | 95851-40-4 | C41H64O13 |
|
—— | (1S,4aS,5R,7aS)-7-(acetoxymethyl)-5-hydroxy-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid | 25368-11-0 | C18H24O12 |
|
—— | [6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate | 94079-81-9 | C35H46O19 |
|
—— | Collettinside IV | 19083-00-2 | C45H72O17 |
|
—— | oleanolic acid 3-O-[β-deglucopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1→2)]-α-L-arabinopyranoside | 103956-33-8 | C47H76O16 |
|
—— | ginsenoside Rc | 11021-14-0 | C53H90O22 |
|
—— | ginsenoside Rb2 | 11021-13-9 | C53H90O22 |
|
—— | trans-(3S,4S)-3,4-dihydroxy-1-tetralone | 1220891-22-4 | C10H10O3 |
|
—— | leontoside B | 17233-22-6 | C41H66O13 |
|
—— | (1S,3R,4S,5R)-3-{[3-(3,4-Dihydroxyphenyl)acryloyl]oxy}-4-[4-(3,4-dihydroxyphenyl)-2-oxobut-3-en-1-yl]-5-hydroxy-1-methylcyclohexane-1-carboxylic acid | 32451-88-0 | C27H28O10 |
|
—— | Marinobufagenin | 470-42-8 | C24H32O5 |
|
—— | (25S)-spirost-5-ene-1β,3β-diol 1-O-<O-α-L-rhamnopyranosyl-(1 <*> 2)-β-D-fucopyranoside> | 38971-41-4 | C39H62O12 |
|
—— | b-D-Glucopyranoside, (3b,6a,12b,24S)-20,24-epoxy-3,12,25-trihydroxydammaran-6-yl | 98474-77-2 | C36H62O10 |
|
—— | Norepinephrine d-bitartrate | 69815-49-2 | C12H19NO10 |
|
—— | Peimisin | 19773-24-1 | C27H41NO3 |
|
—— | Alisol A | 19865-73-7 | C30H50O5 |
|
—— | incensole acetate | 34701-53-6 | C22H36O3 |
|
—— | aescigenin | 426-95-9 | C30H48O5 |
|
—— | Methane;5-methoxy-6-methyl-2-phenylchromenylium-7-ol | 125536-25-6 | C18H19O3+ |
|
—— | 12-Hydroxy-3,7,11,15,23-pentaoxolanost-8-en-26-oic acid | 100665-44-9 | C30H40O8 |
|
—— | (+/-)-triptolide | 38748-32-2 | C20H24O6 |
|
—— | (3S)-3-[[(2S)-5-amino-2-[[(2S)-2-[[(1R,4S,7S,10S,13S,16S,19S,22S,25R,28S,31R,36R,39S,42S,45S)-31-amino-7,22-bis(4-aminobutyl)-39-benzyl-4-(2-carboxyethyl)-10,19-bis(carboxymethyl)-13-[(1R)-1-hydroxyethyl]-28-(hydroxymethyl)-42-[(4-hydroxyphenyl)methyl]-45-(2-methylpropyl)-16-(2-methylsulfanylethyl)-3,6,9,12,15,18,21,24,27,30,38,41,44,47-tetradecaoxo-33,34,49,50-tetrathia-2,5,8,11,14,17,20,23,26,29,37,40,43,46-tetradecazabicyclo[23.22.4]henpentacontane-36-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-oxopentanoyl]amino]-4-[[(2S)-1-[[(2S,3S)-1-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | 120972-53-4 | C110H159N27O34S5 |
|